Trump, drug prices and executive order
Digest more
In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in half or more "almost immediately." But the order is light on details of how the plan would be implemented.
Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices Medicare will pay for pharmaceuticals.
President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making the comments Monday when signing an executive order intended to lower
1d
Money Talks News on MSNNew Medicare Cap Brings $2,474 Average Savings for Drug CostsWorried about skyrocketing prescription drug costs? Medicare's new spending cap is bringing welcome relief to seniors, with 94% of high-cost users expected to save thousands.
It’s unclear what — if any — impact the Republican president’s executive order will have on millions of Americans who have private health insurance.
The president signed an executive order that gives Health and Human Services Secretary Robert F. Kennedy Jr. 30 days to lower drug prices.
When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did
The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early February next year.
Toward the end of his first Administration, Trump signed a similar Executive Order aimed at lowering the prices of some drugs administered in doctor’s offices; that move was blocked by a court order.
The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a new evaluation tool.
CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public comments due by June 26.
Senate Democrats and the Biden administration dropped plans to set drug price caps based on the amount paid in other high-income countries, during talks years ago to push through the law that empowered Medicare to negotiate down the cost of prescription medications.